Psilocybin shows strong promise for depression and treatment resistant depression, with benefits observed in clinical research, SSRI combination studies, and naturalistic surveys. Risks include emotional intensity, cardiovascular changes, and potential complications for individuals with bipolar disorder, psychosis, or those using serotonergic medications. Safe use requires proper screening, therapeutic support, and integration.
Research
